Avidity Biosciences, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2020. For the quarter, the company reported collaboration revenue of USD 2,142,000 against USD 1,445,000 a year ago. Loss from operations was USD 16,293,000 against USD 6,047,000 a year ago. Net loss was USD 16,275,000 against USD 10,401,000 a year ago. Net loss per share, basic was USD 0.43 against USD 3.75 a year ago. For the full year, the company reported collaboration revenue of USD 6,787,000 against USD 2,319,000 a year ago. Loss from operations was USD 44,277,000 against USD 17,332,000 a year ago. Net loss was USD 44,355,000 against USD 24,734,000 a year ago. Net loss per share, basic was USD 2.05 against USD 9.12 a year ago.